Rotkreuzklinikum München
Hospital
Location:
München,
Germany (DE)
ISNI: 0000000404801286
ROR: https://ror.org/04janzm11
Show on Map:
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Response to Neoadjuvant Chemotherapy and Clinical Outcome in Primary Human Breast Cancer (2012)
Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, Hamann S, et al.
Journal article
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial (2010)
Witzel I, Loibl S, Von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, et al.
Journal article